REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 32 filers reported holding REGULUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,096,000 | +14.8% | 3,678,334 | +21.4% | 0.00% | – |
| Q4 2021 | $955,000 | -55.5% | 3,030,213 | -2.4% | 0.00% | – |
| Q3 2021 | $2,145,000 | -14.8% | 3,105,045 | +0.3% | 0.00% | – |
| Q2 2021 | $2,517,000 | -49.9% | 3,095,237 | -3.9% | 0.00% | – |
| Q1 2021 | $5,025,000 | +862.6% | 3,220,758 | +733.0% | 0.00% | – |
| Q4 2020 | $522,000 | +866.7% | 386,659 | +266.7% | 0.00% | – |
| Q3 2020 | $54,000 | +145.5% | 105,449 | +224.4% | 0.00% | – |
| Q2 2020 | $22,000 | +46.7% | 32,503 | 0.0% | 0.00% | – |
| Q1 2020 | $15,000 | -48.3% | 32,503 | 0.0% | 0.00% | – |
| Q4 2019 | $29,000 | +26.1% | 32,503 | 0.0% | 0.00% | – |
| Q3 2019 | $23,000 | -43.9% | 32,503 | 0.0% | 0.00% | – |
| Q2 2019 | $41,000 | -6.8% | 32,503 | -25.4% | 0.00% | – |
| Q1 2019 | $44,000 | -79.0% | 43,573 | -80.6% | 0.00% | – |
| Q4 2018 | $210,000 | – | 225,178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 5,555,555 | $1,656,000 | 0.43% |
| NEA Management Company, LLC | 14,451,147 | $4,306,000 | 0.12% |
| Sarissa Capital Management LP | 1,851,851 | $552,000 | 0.05% |
| Ikarian Capital, LLC | 1,289,130 | $384,000 | 0.05% |
| FEDERATED HERMES, INC. | 29,048,265 | $8,656,000 | 0.02% |
| WealthTrust Axiom LLC | 68,000 | $20,000 | 0.01% |
| All Terrain Financial Advisors, LLC | 15,000 | $4,000 | 0.00% |
| GYL FINANCIAL SYNERGIES, LLC | 34,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124,056 | $37,000 | 0.00% |
| McGuire Investment Group, LLC | 15,000 | $4,000 | 0.00% |